Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Medical Education
  • Medical Admission News
  • Graduate Pharmacy...

Graduate Pharmacy Aptitude Test- GPAT 2024 Registration Begins, Know Schedule, Eligibility Criteria, Fee, Exam Scheme, All Details Here

Divyani PaulWritten by Divyani Paul Published On 2024-04-19T15:47:24+05:30  |  Updated On 19 April 2024 3:47 PM IST
Graduate Pharmacy Aptitude Test- GPAT 2024 Registration Begins, Know Schedule, Eligibility Criteria, Fee, Exam Scheme, All Details Here
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi- The National Board of Examination in Medical Sciences (NBEMS) has invited applications for the Graduate Pharmacy Aptitude Test (GPAT) 2024. On this, NBE has released an information bulletin detailing the important dates, eligibility criteria, fee structure and scheme of examination.

GPAT 2024 is a national-level examination for the award of scholarships to qualified candidates seeking entry into the Master of Pharmacy (M. Pharm) course.

GPAT 2024 is being conducted by NBEMS on June 8, 2024, on a computer-based platform at various testing centres across the country. Meanwhile, the registration process will start today i.e. 19th April 2024 at 3 PM and will continue till 11:55 PM on 8th May 2024. The application can only be submitted online at the NBE official website.

Also Read: NBE to hold Graduate Pharmacy Aptitude Test GPAT 2024 tentatively on June 8: Pharmacy Council of India issues notice

IMPORTANT DATES

S.NO

PROCESSES

TIMELINES

1

Online Submission of Applications

19th April 2024 (3 PM Onwards) to 8th May 2024 (Till 11:55 PM)

2

Edit Window for All Payment Success Applications (Any information/documents can be edited except Name, Nationality, Email, Mobile number and Test City).

11th May 2024 to 14th May 2024

3

Final and Selective Edit Window to rectify Deficient/Incorrect Images (No further opportunity shall be given)-

1 Photograph.

2 Signatures.

3 Thumb Impression.

Pre-Final Edit Window: 21st May to 23rd May 2024 Final Edit Window: 28th May to 30th May 2024

4

Issue of Admit Card.

3rd June 2024

5

Examination Date

8th June 2024

6

Declaration of Result

By 8th July 2024

EXAMINATION FEE

S.NO

CATEGORY OF CANDIDATES

EXAMINATION FEE

1

General, OBC and EWS

Rs. 3500/-

2

SC, ST, PWD

Rs. 2500/-

The application form once submitted cannot be withdrawn as well as the fee can neither be carried forward to a future date nor refunded under any circumstances. Any claim for refund, adjustment or carrying forward of the Application fee will not be entertained.

ELIGIBILITY CRITERIA

1 The candidate should be a citizen of India.

2 The candidate must hold a Bachelor’s degree in Pharmacy (4 years after 10+2, including lateral entry students) or equivalent from a recognised university.

3 Candidates appearing for the final year (4th Year) examination of Bachelor of Pharmacy (B. Pharm) whose results will be declared before commencement of admission to the M. Pharm course for the academic year 2024-25 are eligible to appear in GPAT 2024. Candidates appearing for the Prefinal year (3rd Year) examination of Bachelor of Pharmacy (B. Pharm) whose results for the Final Year (4th Year) will be declared before commencement of admission to the M. Pharm course for the academic year 2025-26 are also eligible to appear in GPAT 2024.

4 B.E./ B.Tech. (Pharmaceutical and Fine Chemical Technology)/ equivalent candidates are not eligible to appear in GPAT 2024.

5 Candidates found to be ineligible at any stage of GPAT 2024 will not be permitted to appear in the examination and/or counselling. In the unlikely event of any ineligible candidate appearing and/or being successful in the GPAT 2024, the results/ candidature of such candidate shall be cancelled and/or will be deemed to be cancelled.

6 Eligibility of candidates issued admit card for the examination shall be purely provisional. Appearance in GPAT 2024 does not confer any automatic rights upon the candidate for admission to M. Pharm courses and/or award of scholarship.

7 Candidates are advised not to canvass with NBEMS for eligibility in GPAT or issuance of admit card. Queries, if any, can be submitted through the Communication Web Portal only. Canvassing in any form shall invite rejection of the application.

SCHEME OF GPAT 2024

SYLLABUS

The syllabus for the GPAT shall comprise the subject/knowledge areas as per “The Bachelor of Pharmacy (B. Pharm.) Course Regulations, 2024”.

The examination shall be a multiple choice questions test delivered using a computer network (CBT) as per the scheme prescribed. An indicative Blueprint of the examination is as under:

S.NO

TYPE OF QUESTIONS

No. OF QUESTIONS

MAXIMUM MARKS

1

Pharmaceutical Chemistry & Allied Subjects

38

152

2

Pharmaceutics & Allied Subjects

38

152

3

Pharmacognosy & Allied Subjects

10

40

4

Pharmacology & Allied Subjects

28

112

5

Other Subjects of B. Pharm course

11

44

TOTAL

125

500

The exam comprises of 125 Multiple Choice Questions with each question having 4 response options/ distractors in the English language only. Candidates are required to select the correct/best/most appropriate response/answer out of the 4 response options provided in each question. The time allotted is 3 hrs (180 minutes).

MARKING SCHEME

S.NO

RESPONSE

MARKS

1

Correct Response

4 Marks

2

Incorrect Response

1 Mark shall be deducted

3

Unattempted Question

Zero

1 There shall be a 25% negative marking for incorrect answers. No marks will be deducted for unattempted questions.

2 The question paper for GAPT will be divided into multiple time-bound sections. For example, if there are 5-time bound sections* (Section A, B, C, D & E) in the question paper, each Section will have 25 questions and 36 minutes allotted for the section. Candidates would be restricted to proceed to the next section only after completion of the allotted time of the previous section and candidates would not be allowed to review the questions/modify the responses of a section after the completion of the allotted time of that section. Questions of the next section will start automatically after the completion of the allotted time of the previous section.

3 Candidates will be given the option to mark any question, whether attempted or not, for review which means that the candidate has been given an option to go through these questions in a section again before the allotted time to a section ends. Candidates may note that such questions which are marked for review shall be evaluated as per the marking scheme mentioned above.

S.NO

ACTIVITIES

TIME

1

Allow Candidates to enter the examination centre and Commence Registration for the test

12:00 PM

2

Entry closes at the Examination Center

01:30 PM

3

Grant access for Candidate Login

01:45 PM

4

Candidates log in to read instructions

01:50 PM

5

Exam Start Time

02:00 PM

6

Exam End Time

05:00 PM

STEPS FOR A COMPUTER-BASED TEST

Submit Online Application Form

⬇️

Edit Application in Edit Window, if required

⬇️

Rectify Images in the Final Edit Window, if asked

⬇️

Watch Demo Test (At NBEMS Website)

⬇️

Download Admit Card

⬇️

Report at Test Centre on Schedule Date &Time

⬇️

Security Check-in Process

⬇️

Registration for Test + Face ID & Biometric Capture

⬇️

Examination Begins

⬇️

During Exam FaceID/Biometric Verification

⬇️

Examination Ends

Also Read: UPSC invites applications for Combined Medical Services- CMS Exam, know registration process, eligibility criteria, exam scheme details

COUNSELLING AND RESERVATION

1 In the case of Institutes run by the Central Government, the reservation would be applicable as mentioned below:

i 15% of the seats for Scheduled Castes (SC) candidates.

ii 7.5% seats for Scheduled Tribes (ST) candidates.

iii 27% seats for Other Backward Classes (OBC) Non-Creamy Layer (NCL) candidates as per the Central List.

iv 10% of the seats for General Economically Weaker Sections (General - EWS) candidates.

2 Each category will have 5% reservations for the candidates with 40% or more disability.

3 In the case of the Institutes run/aided/recognised by State Governments, the reservation policy of the respective State Governments shall be applicable.

4 OBC - NCL (Non-Creamy Layer) as per the Central list of OBC alone are eligible to claim OBC reservation in the counselling/admission. All OBC applicants for GPAT are accordingly advised to indicate their category as OBC in the application form only if their caste belongs to the Central list of OBCs and they fall under the non-creamy layer.

5 ।NBEMS has no role in counselling for admission to the Masters (M.Pharma) program. Candidates must apply separately to the desired GPAT-2024 Participating institutions with the GPAT Score 2024. Thereafter, each Participating Institute will release its respective cut-off GPAT Scores which a candidate should meet to qualify for admission to that particular Institution.

6 Candidates are advised to read the details of the admission process of each Participating Institute of GPAT-2024 on their respective websites. The participating Institutions of GPAT-2024 are the Institutions which will be accepting the GPAT Scores.

7 Admission to PG courses are undertaken by the State Government/ State admission committee. NBEMS has no role whatsoever in the conduct of counselling for admission to M. Pharm/ PhD courses utilising GPAT scores.

To view the information bulletin, click the link below

https://medicaldialogues.in/pdf_upload/nbems-information-bulletinjpg-236496.pdf
National Board of Examination in Medical SciencesGraduate Pharmacy Aptitude TestGPATNBEnatboardpharmacynbe
Divyani Paul
Divyani Paul

    I am a student of Journalism and Mass Communication and also a passionate writer and explorer. With a keen interest in medicine, I have joined Medical Dialogues as a Content Writer. Within this role, I curate various healthcare-related news including the latest updates on health, hospitals, and regulatory updates from NMC/DCI. For any query or information, feel free to reach out to me at editorial@medicaldialogues.in

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok